Author

S. Lonardi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores.

BACKGROUND & AIMS The management of comorbidities has become increasingly relevant in unresectable hepatocellular carcinoma (uHCC) as immunotherapy prolongs survival. Atezolizumab plus bevacizumab (AB) is a standard first-line option, but bevacizumab carries a risk of cardiovascular toxicities. Data on cardiovascular r...

B. Stefanini, L. Rimassa, M. Iavarone et al. · Liver international (Print) · 0 citations

Open access Aug 2026

Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center

PURPOSE Comprehensive genomic profiling (CGP) is increasingly adopted in the management of patients affected by GI cancers. However, the applicability, performance, and clinical utility of CGP in the real-world setting are still undefined. METHODS We retrospectively evaluated CGP performance and clinical benefit in con...

G. Maddalena, Valentina Angerilli, F. Nichetti et al. · JCO Precision Oncology · 0 citations

Review Open access Aug 2026

Deciphering the Molecular Landscape of Squamous Cell Carcinoma of the Anal Canal: From Biology to Precision Oncology

Simple Summary Squamous cell carcinoma of the anal canal (SCAC) is a rare malignancy whose incidence has been increasing worldwide. The main etiological factor is HPV infection, particularly in association with HIV infection and other immunosuppressive conditions. The majority of patients present with localized disease...

Matilde Callegarin, Valentina Angerilli, J. Gasparello et al. · Cancers · 0 citations